Biotin
FDA-approved product (injectable, injection).
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 1 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Anemia (phenotype)
- Chronic kidney disease
- Iron deficiency anemia
- Type 2 diabetes mellitus
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Other plain vitamin preparations
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against K. pneumoniae. It was surfaced computationally for further investigation; it is not an established treatment for this infection.
AI-predicted activity
AI prediction · nothing measured- MRSA31.9% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli19.8% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae40.3% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- M. tuberculosis14.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Biotin with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- FurazolidoneExisting use: Other antiinfectives and antiseptics91.4% AI-predicted activityagainst M. tuberculosisLab records exist49 registered studies
- TriflupromazineExisting use: Psychosis90.6% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- ValdecoxibExisting use: Dysmenorrhea, Osteoarthritis, Rheumatic disease and 1 more88.6% AI-predicted activityagainst M. tuberculosisLab records exist31 registered studies
- CelecoxibExisting use: Ankylosing spondylitis, Cancer, Colorectal neoplasm and 15 more87.6% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Dorzolamide HydrochlorideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma86.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- MethazolamideExisting use: Glaucoma, Open-angle glaucoma85.6% AI-predicted activityagainst M. tuberculosisLab records exist11 registered studies
- AcetazolamideExisting use: Altitude sickness, Angle-closure glaucoma, Congestive heart failure and 5 more85.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Trifluoperazine HydrochlorideExisting use: Anxiety disorder, Mental or behavioural disorder, Psychosis and 1 more84.6% AI-predicted activityagainst M. tuberculosis1 registered study
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives84.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- NitrofurazoneExisting use: Eye infection, Leishmaniasis, Trypanosomiasis84.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- BrinzolamideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma83.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- ZonisamideExisting use: Epilepsy, Focal-onset seizure, Partial epilepsy and 1 more82.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Micronutrient Dose Response Study in Bangladesh
NCT06081114 · start 2023-10-22
Registered record
- Registry ID
- NCT06081114
- Conditions
- Micronutrient Status
- Interventions
- Micronutrient Supplement
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Active not recruiting
- Start
- 2023-10-22
- Completion
- 2027-12-31
- Enrolment
- 643
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMicronutrient StatusInterventionMicronutrient SupplementPhaseNot applicableRegistry statusActive not recruitingUse of Ritual Prenatal Multivitamins for Pregnancy
NCT05673070 · start 2023-10-15
Registered record
- Registry ID
- NCT05673070
- Conditions
- Pregnancy Related; Nutrition, Healthy
- Interventions
- Ritual Epre Multivitamin-mineral supplement; control MVI
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2023-10-15
- Completion
- 2024-12-31
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPregnancy Related; Nutrition, HealthyInterventionRitual Epre Multivitamin-mineral supplement; control MVIPhaseNot applicableRegistry statusCompletedA Clinical Study to Assess the Safety and Effectiveness of Plant-based Biotin and Plant Based Biotin with Silica in Healthy Human Subjects with Complaints of Hair Fall, Thin, Dry, & Brittle Hair, and Dry Skin
NCT05972512 · start 2023-08-22
Registered record
- Registry ID
- NCT05972512
- Conditions
- Hair Falling; Thin Hair; Dry Hair; Brittle Hair; Dry Skin
- Interventions
- Placebo; Botanical extract of standardized biotin; Botanical extract of standardised biotin with silica
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2023-08-22
- Completion
- 2023-12-14
- Enrolment
- 105
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHair Falling; Thin Hair; Dry Hair; Brittle Hair +1 moreInterventionPlacebo; Botanical extract of standardized biotin; Botanical extract of standardised biotin with silicaPhaseNot applicableRegistry statusCompletedCorrecting GUT MicrobioTa by Combined Supplementation of FibERs and BIotiN to Improve Microbiome and Optimize Bariatric Surgery Outcomes
NCT05832190 · start 2023-07-24
Registered record
- Registry ID
- NCT05832190
- Conditions
- Severe Obesity; Metabolic Syndrome
- Interventions
- Standard of care; Biotin supplement; Fiber supplement
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2023-07-24
- Completion
- 2024-12-24
- Enrolment
- 5
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSevere Obesity; Metabolic SyndromeInterventionStandard of care; Biotin supplement; Fiber supplementPhaseNot applicableRegistry statusTerminatedA Clinical Study to Assess the Safety and Effectiveness of Plant Based Biotin in Healthy Human Subjects With Thin, Dry, and Brittle Hair
NCT05800496 · start 2022-10-31
Registered record
- Registry ID
- NCT05800496
- Conditions
- Hair Thinning; Hair Brittle; Dry Hair
- Interventions
- SesZen-Bio™; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2022-10-31
- Completion
- 2023-01-10
- Enrolment
- 54
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHair Thinning; Hair Brittle; Dry HairInterventionSesZen-Bio™; PlaceboPhaseNot applicableRegistry statusCompletedCan Biotin Supplementation be Used to Mask hCG Abuse?
NCT05450900 · start 2022-10-27
Registered record
- Registry ID
- NCT05450900
- Conditions
- Healthy
- Interventions
- Choriogonadotropin Alpha; biotin; Microcellulose filler
- Study type
- INTERVENTIONAL
- Phase
- Early phase 1
- Registry status
- Completed
- Start
- 2022-10-27
- Completion
- 2023-02-02
- Enrolment
- 10
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthyInterventionChoriogonadotropin Alpha; biotin; Microcellulose fillerPhaseEarly phase 1Registry statusCompletedThe Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma
NCT05632549 · start 2022-08-08
Registered record
- Registry ID
- NCT05632549
- Conditions
- Moderate Persistent Asthma
- Interventions
- Placebo; L-Carnitine 500Mg Oral Tablet; Biotin Capsules
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2022-08-08
- Completion
- 2024-08-08
- Enrolment
- 66
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionModerate Persistent AsthmaInterventionPlacebo; L-Carnitine 500Mg Oral Tablet; Biotin CapsulesPhasePhase 3Registry statusUnknownAn Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits
NCT05523115 · start 2022-06-15
Registered record
- Registry ID
- NCT05523115
- Conditions
- Anxiety; Stress; Memory Deficits; Cortisol Overproduction
- Interventions
- Heights Smart Supplement
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2022-06-15
- Completion
- 2022-10-01
- Enrolment
- 34
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnxiety; Stress; Memory Deficits; Cortisol OverproductionInterventionHeights Smart SupplementPhaseNot applicableRegistry statusCompletedEffects of an Acute Dose of Caffeine on the Performance of CrossFit Athletes
NCT06891469 · start 2022-01-22
Registered record
- Registry ID
- NCT06891469
- Conditions
- Healthy, Young Adults; Athletic Performance
- Interventions
- Caffeine administration according to body mass (moderate intake- 7 mg/kg); Placebo (Biotin Capsules)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2022-01-22
- Completion
- 2022-05-29
- Enrolment
- 12
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthy, Young Adults; Athletic PerformanceInterventionCaffeine administration according to body mass (moderate intake- 7 mg/kg); Placebo (Biotin Capsules)PhaseNot applicableRegistry statusCompletedRed Cell Half Life Determination in Patients With and Without Sickle Cell Disease
NCT04476277 · start 2021-04-19
Registered record
- Registry ID
- NCT04476277
- Conditions
- Sickle Cell Disease; Sickle Cell Anemia
- Interventions
- Biotin label
- Study type
- INTERVENTIONAL
- Phase
- Early phase 1
- Registry status
- Completed
- Start
- 2021-04-19
- Completion
- 2023-02-14
- Enrolment
- 22
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSickle Cell Disease; Sickle Cell AnemiaInterventionBiotin labelPhaseEarly phase 1Registry statusCompletedIntervention for Multivitamin Adherence on Bariatric Patients
NCT04612088 · start 2020-09-14
Registered record
- Registry ID
- NCT04612088
- Conditions
- Adherence, Medication
- Interventions
- Cognitive Dissonance
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2020-09-14
- Completion
- 2021-05-24
- Enrolment
- 34
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAdherence, MedicationInterventionCognitive DissonancePhaseNot applicableRegistry statusUnknownStudy of the Effect of 12-week Dietary Supplementation With a Multicomponent Nutritional Supplement on Nails and Skin
NCT05100680 · start 2019-11-25
Registered record
- Registry ID
- NCT05100680
- Conditions
- Nail Damage
- Interventions
- Multicomp; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-11-25
- Completion
- 2020-09-01
- Enrolment
- 34
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNail DamageInterventionMulticomp; PlaceboPhaseNot applicableRegistry statusCompletedTQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects
NCT04168723 · start 2019-11-11
Registered record
- Registry ID
- NCT04168723
- Conditions
- Healthy Volunteers
- Interventions
- MD1003; Moxifloxacin 400mg; Placebo for MD1003; Placebo for moxifloxacin
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Unknown
- Start
- 2019-11-11
- Completion
- 2020-03-05
- Enrolment
- 64
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthy VolunteersInterventionMD1003; Moxifloxacin 400mg; Placebo for MD1003; Placebo for moxifloxacinPhasePhase 1Registry statusUnknownTransfusion of Biotin-Labeled Red Blood Cells
NCT03364686 · start 2019-09-16
Registered record
- Registry ID
- NCT03364686
- Conditions
- Healthy Volunteers
- Interventions
- Biotin-Labeled Red Blood Cells
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Terminated
- Start
- 2019-09-16
- Completion
- 2021-06-29
- Enrolment
- 6
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthy VolunteersInterventionBiotin-Labeled Red Blood CellsPhasePhase 2Registry statusTerminatedDietary Supplementation in Heart Failure
NCT03980574 · start 2019-04-01
Registered record
- Registry ID
- NCT03980574
- Conditions
- Heart Failure
- Interventions
- R Drink
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-04-01
- Completion
- 2020-06-29
- Enrolment
- 10
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHeart FailureInterventionR DrinkPhaseNot applicableRegistry statusCompleted